Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Public ClinicalTrials.gov record NCT02228681. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II Trial of Everolimus and Letrozole or Hormonal Therapy (Tamoxifen/Medroxyprogesterone Acetate) in Women With Advanced, Recurrent, or Persistent Endometria Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the effectiveness of the combination of the drugs Everolimus and Letrozole compared to Tamoxifen and Medroxyprogesterone acetate in treating endometrial cancer and to determine the types and severity of side effects caused by treatment with these drug combinations.
Study identification
- NCT ID
- NCT02228681
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 74 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 20, 2015
- Primary completion
- Dec 31, 2017
- Completion
- Aug 21, 2024
- Last update posted
- Sep 18, 2024
2015 – 2024
United States locations
- U.S. sites
- 26
- U.S. states
- 19
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Colorado - Anschutz Cancer Pavilion | Aurora | Colorado | 80045 | — |
| University of Miami - Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| John B. Amos Cancer Center | Columbus | Georgia | 31904 | — |
| Memorial Health University Medical Center | Savannah | Georgia | 31404 | — |
| Maine Medical Center | Scarborough | Maine | 04074 | — |
| Johns Hopkins | Baltimore | Maryland | 21287 | — |
| University of Massachusetts Memorial Center | Worcester | Massachusetts | 01605 | — |
| Sanford Clinic North - Bemidji | Bemidji | Minnesota | 56601 | — |
| St. Dominic-Jackson Memorial Hospital | Jackson | Mississippi | 39215 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Women's Cancer Center of Nevada | Las Vegas | Nevada | 89169 | — |
| New Mexico Cancer Alliance | Albuquerque | New Mexico | 87106 | — |
| Memorial Medical Center-Cancer Center | Albuquerque | New Mexico | 87131 | — |
| Women's Cancer Care Associates | Albany | New York | 12208 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Sanford Roger Maris Cancer Center | Fargo | North Dakota | 58122 | — |
| University Hospital Case Medical Center | Cleveland | Ohio | 44106 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001-3788 | — |
| The University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Magee Women's Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Women & Infants Hospital of Rhode Island | Providence | Rhode Island | 02905 | — |
| Sanford Medical Center - Sioux Falls | Sioux Falls | South Dakota | 57104 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02228681, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2024 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02228681 live on ClinicalTrials.gov.